• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Real-World Versus Guideline-Based Treatments For Chronic Spontaneous Urticaria Among Commercially-Insured Versus Medicaid Patients In The United States
Guideline-recommended treatments for patients with chronic spontaneous urticaria (CSU) have evolved. We sought to identify how real-world treatments align with current guidelines among commercially-insured and Medicaid patients.
Source: Journal of Allergy and Clinical Immunology - February 1, 2023 Category: Allergy & Immunology Authors: Vincent Garmo, Arpamas Seetasith, Sheila Reddy, Eunice Chang, Marian Tarbox, Michael Holden, Thomas Casale Source Type: research

New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately to severely acti...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

‘This Is Really Life or Death.’ For People With Disabilities, Coronavirus Is Making It Harder Than Ever to Receive Care
Jeiri Flores is normally a busy, upbeat 29-year-old. But amid the COVID-19 pandemic, her go-to thought has been dark. “If I get this,” she thinks, “I’m gonna die.” This is not an unfounded fear. Flores has cerebral palsy, uses a wheelchair and needs assistance with everyday tasks, including making food and getting dressed. Her disability means it’s tougher for her immune system to kick illnesses; she’s still recovering from a bout of pneumonia she had in January. So beating COVID-19 could easily mean a protracted battle and months in a hospital—a prospect that comes with a c...
Source: TIME: Health - April 24, 2020 Category: Consumer Health News Authors: Abigail Abrams Tags: Uncategorized COVID-19 Source Type: news

Biologic Logistics: Connecting with your patients on biologics
The use of biologics has breathed new life into asthma management. They have provided truly life changing improvement for those with atopic dermatitis, chronic idiopathic urticaria, and chronic rhinosinusitis with nasal polyposis. After a biologic has been chosen, the next challenge is making the medication available to the patient. Ongoing changes in medication delivery like at-home administration, insurance coverage, and reimbursement have made prescribing biologics and monitoring these patients a moving target.
Source: Annals of Allergy, Asthma and Immunology - January 28, 2020 Category: Allergy & Immunology Authors: Jared Darveaux Tags: Perspective Source Type: research

Biologic logistics
The use of biologics has breathed new life into asthma management. They have provided truly life-changing improvement for those with atopic dermatitis, chronic idiopathic urticaria, and chronic rhinosinusitis with nasal polyposis. After a biologic has been chosen, the next challenge is making the medication available to the patient. Ongoing changes in medication delivery, such as at-home administration, insurance coverage, and reimbursement, have made prescribing biologics and monitoring these patients a moving target.
Source: Annals of Allergy, Asthma and Immunology - January 28, 2020 Category: Allergy & Immunology Authors: Jared Darveaux Tags: Perspective Source Type: research

Why Parents Are Turning to a Controversial Treatment for Food Allergies
This article was originally published on Undark. Read the original article.
Source: TIME: Health - August 15, 2019 Category: Consumer Health News Authors: Esther Landhuis / Undark Tags: Uncategorized allergies health onetime syndication Source Type: news

Epidemiology of Chronic Urticaria in Korea Using the Korean Health Insurance Database, 2010-2014.
CONCLUSIONS: The present study outlines recent longitudinal epidemiological data on the prevalence of CU in Korea. In light of limitations on the use of claims data, including no specific disease code for CU and a possible discordance between drug claims and the presence of urticaria symptoms, further investigations are necessary to describe the exact epidemiologic profile of CU patients. PMID: 28677358 [PubMed]
Source: Allergy, Asthma and Immunology Research - July 6, 2017 Category: Allergy & Immunology Tags: Allergy Asthma Immunol Res Source Type: research

Birth month and risk of atopic dermatitis: a nationwide population ‐based study
ConclusionBeing born in December, October, or November may be associated with an increased risk of AD. Future investigations are needed to evaluate the possible mechanism behind the association between birth month and AD.
Source: Allergy - June 29, 2016 Category: Allergy & Immunology Authors: C. L. Kuo, T. L. Chen, C. C. Liao, C. C. Yeh, C. L. Chou, W. R. Lee, J. G. Lin, C. C. Shih Tags: Original Article Source Type: research

Birth month and risk of atopic dermatitis: a nationwide population‐based study
ConclusionBeing born in December, October, or November may be associated with an increased risk of AD. Future investigations are needed to evaluate the possible mechanism behind the association between birth month and AD.This article is protected by copyright. All rights reserved.
Source: Allergy - May 31, 2016 Category: Allergy & Immunology Authors: C.L. Kuo, T.L. Chen, C.C. Liao, C.C. Yeh, C.L. Chou, W.R. Lee, J.G. Lin, C.C. Shih Tags: Original Article: Skin and Eye Diseases Source Type: research

Association between chronic idiopathic urticaria and hypertension: A population-based retrospective cohort study.
CONCLUSION: This nationwide retrospective cohort study found that CIU is associated with a higher future risk of hypertension after adjusting for sex, age, comorbidities, and nonsedating antihistamine use. The detailed pathophysiologic mechanisms require further clarification in prospective studies. PMID: 27264565 [PubMed - as supplied by publisher]
Source: Annals of Allergy, Asthma and Immunology - May 31, 2016 Category: Allergy & Immunology Authors: Chang HW, Cheng HM, Yen HR, Hsu CY, Lee YC, Chiang JH, Sun MF Tags: Ann Allergy Asthma Immunol Source Type: research

Effect of chronic urticaria on US patients: analysis of the National Health and Wellness Survey.
CONCLUSION: Chronic hives substantially affects quality of life, nonwork activities, capacity to work, and health care use, providing further evidence of a high burden of CIU/CSU across multiple health outcomes and unmet need for effective treatment. PMID: 26265010 [PubMed - as supplied by publisher]
Source: Annals of Allergy, Asthma and Immunology - August 8, 2015 Category: Allergy & Immunology Authors: Vietri J, Turner SJ, Tian H, Isherwood G, Balp MM, Gabriel S Tags: Ann Allergy Asthma Immunol Source Type: research

Increased risk of major depression subsequent to a first-attack and non-infection caused urticaria in adolescence: A nationwide population-based study
Conclusion: Individuals who have a non-infection caused urticaria during adolescence are at a higher risk of developing major depression.
Source: BMC Pediatrics - Latest articles - July 11, 2014 Category: Pediatrics Authors: Chia-Lun KuoChi-Yen ChenHui-Ling HuangWen-Liang ChenHua-Chin LeeChih-Yu ChangChu-Chung ChouShinn-Ying HoHan-Ping WuYan-Ren Lin Source Type: research